U.S. market Open. Closes in 3 hours 40 minutes

RNLX | Renalytix Plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-30
Revenue3.40M2.97M1.49MN/AN/A
Cost of Revenue2.70M2.05M804.00K74.00K30.99K
Gross Profit701.00K918.00K687.00K-74.00K-30.99K
Operating Expenses43.06M58.29M33.30M11.08M6.54M
Selling, General & Admin43.06M12.95M8.37M11.08M6.54M
Research & Development14.30M14.65M10.04M4.57M39.60M
Other Operating Expenses656.00K30.69M14.88MN/AN/A
Operating Income-42.35M-57.37M-32.61M-11.08M-6.54M
Other Expenses / Income-3.38M7.74M-3.18M468.00K19.00K
Before Tax Income-46.22M-49.63M-35.79M-10.61M-6.52M
Income Tax Expenses2.00K7.10M-4.78M-1.36M-959.00K
Net Income-46.22M-56.73M-31.01M-9.25M-5.56M
Interest ExpensesN/A2.00K3.00K2.00K20.00K
Basic Shares Outstanding41.11M36.43M35.74M29.54M21.28M
Diluted Shares Outstanding41.11M36.43M35.74M29.54M21.28M
EBITDA-35.50M-45.11M-39.41M-11.08M-5.37M
EBITDA Margin-1,043.11%-1,518.89%-2,643.26%0.00%0.00%
EBIT-46.22M-49.63M-35.78M-10.61M-6.50M
EBIT Margin-1,358.24%-1,670.91%-2,400.07%0.00%0.00%
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙